To address this issue in a controlled ‘in vitro’ model, we investigated the invasive potential of CD44+/CD166+ or CD44−/CD166− cells derived from the human colorectal cancer cell lines, LS180, SW480, and Colo205. This evidence concerns the gene CD44 and colorectal cancer.